Alizapride
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral, IM, IV |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 3 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| ECHA InfoCard | 100.056.082 |
| Chemical and physical data | |
| Formula | C16H21N5O2 |
| Molar mass | 315.377 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Alizapride (Litican, Plitican, Superan, Vergentan) is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.
|
Drugs for functional gastrointestinal disorders (A03)
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
|
||||||||||||
|
Belladonna and derivatives (antimuscarinics) |
|
||||||||||||
| Propulsives | |||||||||||||